Insider trades
Ankit Mahadevia, Director of Spero Therapeutics SPRO, has filed 0 purchases and 7 sales on the open market. The latest trade was on 25/08/28.
Ankit Mahadevia
Director
- Company
- Spero Therapeutics SPRO
- First filing
- 23/02/03
- Trades
- 11 trades
- Buys / sales
- 0 / 7
- 12-month net buying
- No record
- Last trade
- 25/08/28
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 25/08/28 | 25/09/03 | 6,572 sh | $1.97 | $12,946.84 | −0.9% | |
SPRO | Open-market sale | 25/02/05 | 25/02/05 | 69,219 sh2 trades | $0.78avg. | $53,990.82 | −9.1% |
| Open-market sale | 24/08/27 | 24/08/29 | 5,912 sh | $1.35 | $7,981.2 | −0.8% | |
| Open-market sale | 24/02/02 | 24/02/05 | 63,795 sh | $1.37 | $87,399.15 | −7.9% | |
| Open-market sale | 23/08/28 | 23/08/30 | 9,040 sh | $1.26 | $11,390.4 | −1.1% | |
| Open-market sale | 23/02/03 | 23/02/06 | 12,286 sh | $1.81 | $22,237.66 | −1.5% |